Accelerating Clinical Trials in the EU (ACT EU) is an initiative developed by the European Commission, Heads of Medicines Agencies and the European Medicines Agency to transform the clinical trials landscape in the European Union. It aims to foster regulatory, technological and process innovation to support better, faster and optimized clinical trials.

中文翻译：

---

加速欧盟临床试验（ACT EU）：改变欧盟临床试验格局


加速欧盟临床试验 (ACT EU) 是由欧盟委员会、药品机构负责人和欧洲药品管理局制定的一项举措，旨在改变欧盟的临床试验格局。它旨在促进监管、技术和流程创新，以支持更好、更快和优化的临床试验。